Tau gene (MAPT) sequence variation among primates.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 15474313)

Published in Gene on October 27, 2004

Authors

Max Holzer1, Molly Craxton, Ross Jakes, Thomas Arendt, Michel Goedert

Author Affiliations

1: MRC Laboratory of Molecular Biology, Cambridge, UK. holm@medizin.uni-leipzig.de

Articles citing this

The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med (2010) 1.86

The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Hum Genet (2010) 1.31

Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol (2008) 1.27

Tau isoform composition influences rate and extent of filament formation. J Biol Chem (2012) 1.11

Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des (2012) 1.06

Postnatal stem/progenitor cells derived from the dental pulp of adult chimpanzee. BMC Cell Biol (2008) 0.99

Tau splicing and the intricacies of dementia. J Cell Physiol (2012) 0.94

Regulation of human MAPT gene expression. Mol Neurodegener (2015) 0.90

Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging. Age (Dordr) (2012) 0.86

Tau aggregation and toxicity in tauopathic neurodegenerative diseases. J Alzheimers Dis (2008) 0.84

Detection of gene expression changes at chromosomal rearrangement breakpoints in evolution. BMC Bioinformatics (2012) 0.79

The domestic cat as a natural animal model of Alzheimer's disease. Acta Neuropathol Commun (2015) 0.77

An evolutionary roadmap to the microtubule-associated protein MAP Tau. BMC Genomics (2016) 0.77

Saitohin, which is nested within the tau gene, interacts with tau and Abl and its human-specific allele influences Abl phosphorylation. J Cell Biochem (2011) 0.76

Analysis of Five Gene Sets in Chimpanzees Suggests Decoupling between the Action of Selection on Protein-Coding and on Noncoding Elements. Genome Biol Evol (2015) 0.75

Noncoding RNAs in neurodegeneration. Nat Rev Neurosci (2017) 0.75

Association of rs62063857 variant of the saitohin gene with Parkinson's disease. Cell Mol Neurobiol (2014) 0.75

Saitohin Q7R polymorphism is associated with late-onset Alzheimer's disease susceptibility among caucasian populations: a meta-analysis. J Cell Mol Med (2017) 0.75

Articles by these authors

Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50

GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov (2004) 3.93

Regional patterns of gene expression in human and chimpanzee brains. Genome Res (2004) 3.84

A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell (2009) 3.63

Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci (2002) 2.80

Tau pathology and neurodegeneration. Lancet Neurol (2013) 2.66

Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A (2013) 2.27

Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta (2005) 2.24

The cholinergic system in aging and neuronal degeneration. Behav Brain Res (2010) 2.23

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem (2004) 2.11

Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem (2002) 2.07

Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J (2003) 2.07

Tissue transglutaminase is not a biochemical marker for Alzheimer's disease. Neurobiol Aging (2013) 2.00

p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J (2005) 1.90

Proteasomal degradation of tau protein. J Neurochem (2002) 1.88

Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol (2004) 1.72

Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry (2006) 1.69

Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc Natl Acad Sci U S A (2003) 1.67

Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett (2004) 1.60

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci (2006) 1.57

Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain (2012) 1.55

Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci (2007) 1.52

Impact of cellular senescence signature on ageing research. Ageing Res Rev (2010) 1.47

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain (2010) 1.38

Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J Alzheimers Dis (2002) 1.34

Interaction of tau protein with the dynactin complex. EMBO J (2007) 1.33

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol (2014) 1.32

Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am J Pathol (2007) 1.32

PART is part of Alzheimer disease. Acta Neuropathol (2015) 1.31

Synaptotagmin interaction with the syntaxin/SNAP-25 dimer is mediated by an evolutionarily conserved motif and is sensitive to inositol hexakisphosphate. J Biol Chem (2004) 1.30

A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. Protein Sci (2007) 1.22

White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol (2008) 1.21

Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci U S A (2010) 1.21

Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope. J Neurochem (2006) 1.21

The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain (2007) 1.18

Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett (2009) 1.17

Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem (2004) 1.17

Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2. Biochem J (2004) 1.16

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex (2004) 1.14

In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain. J Neurochem (2008) 1.13

Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies. FEBS Lett (2007) 1.12

Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am J Pathol (2004) 1.11

Cysteine misincorporation in bacterially expressed human alpha-synuclein. FEBS Lett (2006) 1.10

Sequence Determinants for Amyloid Fibrillogenesis of Human alpha-Synuclein. J Mol Biol (2007) 1.09

Structural correlates of mild cognitive impairment. Neurobiol Aging (2004) 1.09

The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates. Chemistry (2013) 1.09

Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice. Brain Res (2006) 1.08

Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res (2002) 1.08

A role for FKBP52 in Tau protein function. Proc Natl Acad Sci U S A (2010) 1.07

Cell-mediated neuroprotection in a mouse model of human tauopathy. J Neurosci (2010) 1.07

Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol (2002) 1.07

Circadian clocks and neurodegenerative diseases: time to aggregate? Curr Opin Neurobiol (2013) 1.07

Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly. J Cell Sci (2005) 1.06

The value of incomplete mouse models of Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 1.06

"Prion-like" templated misfolding in tauopathies. Brain Pathol (2013) 1.06

Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging (2006) 1.05

AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis (2002) 1.05

Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry (2006) 1.04

Perineuronal nets potentially protect against oxidative stress. Exp Neurol (2004) 1.03

A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. Eur J Biochem (2002) 1.03

Tau oligomers impair artificial membrane integrity and cellular viability. J Biol Chem (2012) 1.03

Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies. J Neurosci (2013) 1.02

Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur J Neurosci (2007) 1.02

Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol Aging (2009) 1.01

Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. Am J Neurodegener Dis (2012) 1.01

Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS Lett (2008) 1.00

Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. FEBS Lett (2009) 1.00

Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol (2012) 0.99

Comparative analysis of tandem C2 domains from the mammalian synaptotagmin family. Biochem J (2004) 0.99

Early behavioural markers of disease in P301S tau transgenic mice. Behav Brain Res (2009) 0.99

Systematic analysis of gene expression in human brains before and after death. Genome Biol (2005) 0.98

Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PLoS One (2013) 0.98

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol (2013) 0.97

Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One (2012) 0.97

Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Neurobiol Dis (2004) 0.96

Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus (2007) 0.94

Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci (2005) 0.94

Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm (Vienna) (2011) 0.94

Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene. Acta Neuropathol (2005) 0.92

A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease. Ann Neurol (2002) 0.92

Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem (2006) 0.92

Expression of cell cycle-related proteins in developing and adult mouse hippocampus. Int J Dev Neurosci (2005) 0.91

Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J Parkinsons Dis (2013) 0.91

The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS One (2011) 0.91

Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathol (2012) 0.90

Complementary distribution of vesicular glutamate transporters 1 and 2 in the nucleus accumbens of rat: Relationship to calretinin-containing extrinsic innervation and calbindin-immunoreactive neurons. J Comp Neurol (2003) 0.90

Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. J Neurosci Res (2006) 0.90

A putative role for cell cycle-related proteins in microtubule-based neuroplasticity. Eur J Neurosci (2009) 0.89

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation (2005) 0.89

Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau. PLoS One (2012) 0.89

Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol (2002) 0.88

Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases in intact cells. FEBS Lett (2002) 0.88

Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy (2012) 0.87